… inactivation rate constant (k inact ) playing a more significant role in the binding event, due
to covalent bond formation, than the inhibition constant (k i ) resulting from reversible binding. …

… Alexander Elder contributed to the supervision and training of the study nurses, Lesley
Wallace and Karen McAuley did the laboratory analyses. Gordon Murray prepared the …

We present the results of a multicenter clinical trial using Epstein-Barr virus (EBV)–specific
cytotoxic T lymphocytes (CTLs) generated from EBV-seropositive blood donors to treat …

Polymer gel dosimeters are fabricated from radiation sensitive chemicals which, upon
irradiation, polymerize as a function of the absorbed radiation dose. These gel dosimeters, with …

… In 2020, they reported an expansion of this work, including multiparameter kinetic analysis
to determine the inhibition constant (k i ) and inactivation rate constant (k inact ) [74]. By …

Background . A vaccine against Epstein-Barr virus (EBV) infection is in clinical trials. Up-to-date
information on risk factors for EBV infection and infectious mononucleosis (IM) among …

BACKGROUND & AIMS:: Studies have indicated that stem cells have unexpected plasticity
and can differentiate down a multitude of nonhematopoietic cell lineages in rodents. Our aim …

The role of antigen‐specific CD3 + CD8 + cytotoxic T cells in the control of primary Epstein–Barr
Virus (EBV) infection is well established. However, time is required for the antigen‐…

Background. Risk factors for primary infection with Epstein-Barr virus (EBV) and its subtypes
have not been fully investigated. Methods. Questionnaires and serum samples from a total …

To determine the role of sexual contact in transmission of Epstein-Barr virus (EBV) and
occurrence of infectious mononucleosis (IM), a cross-sectional study was undertaken of EBV …